ARIAD to Host Analyst & Investor Day in New York City
June 08 2016 - 7:35AM
Business Wire
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that
it will host an Analyst & Investor Day for its research
analysts and institutional investors on Friday, June 17 at 8:30
a.m. (EDT) in New York City. Paris Panayiotopoulos, president and
chief executive officer of ARIAD, will host the event along with
other key members of ARIAD senior management. The meeting will
focus on ARIAD’s completion of its corporate strategic review, as
well as provide an update on continued progress in its research and
development and commercial programs. Expert medical leaders in the
fields of chronic myeloid leukemia and non-small cell lung cancer
will be featured speakers and discussants at the meeting.
A live webcast of the Analyst & Investor Day can be accessed
by visiting the investor relations section of ARIAD’s website at
http://www.ariad.com/investor.
About ARIAD
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge,
Massachusetts is an orphan oncology company focused on transforming
the lives of cancer patients with breakthrough medicines. ARIAD is
working on new medicines to advance the treatment of various forms
of chronic and acute leukemia, lung cancer and other orphan
cancers. ARIAD utilizes computational and structural approaches to
design small-molecule drugs that overcome resistance to existing
cancer medicines. For additional information, visit
http://www.ariad.com or follow ARIAD on Twitter
(@ARIADPharm).
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160608005162/en/
ARIAD Pharmaceuticals, Inc.For InvestorsManmeet S. Soni,
617-503-7298Manmeet.soni@ariad.comorFor MediaLiza Heapes,
617-621-2315Liza.heapes@ariad.com
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From May 2024 to Jun 2024
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Jun 2023 to Jun 2024